Daily Headlinez Top News Updates
NEW DELHI: The new generation of weight-loss injections — already popular globally — is now showing strong results in Indian patients too. A fresh study from a Delhi hospital finds that more than 4 in 10 people lost at least 10% of their body weight, a level doctors say can significantly improve overall health.The research,…
Eli Lilly and Cipla announced an agreement to distribute and promote tirzepatide in India under a second brand name, Yurpeak. This strategic agreement aims to expand the availability of tirzepatide by enabling broader access across the country beyond cities where Lilly already has an established presence. In March, Lilly launched its blockbuster weight-loss therapy, tirzepatide…
NEW DELHI: The World Health Organization (WHO) has included popular weight-loss drugs like Semaglutide and Tirzepatide, sold in India under the brand name Wegovy and Mounjaro, respectively, in its Model List of Essential Medicines (EML).This is important because the WHO’s model list of essential medicines serves as a basis for public sector procurement, supply of…
